Our coverage on the latest scoop
News and Media Releases
Health Research Ethics Board of Alberta Approves ATMA’s Phase II Psilocybin Clinical Trial with Group and Individual Therapy Settings
This trial will assess the efficacy of psilocybin-assisted therapy in...
READ MORE
ATMA Expands Practitioner In-Person Clinical Training to Bridge with Psychedelic-Assisted Therapy Clinical Practice
CALGARY, AB, April 11, 2024 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), a pioneering...
READ MORE
ATMA CENA Celebrates Groundbreaking Support from Alberta Blue Cross for Psychedelic Assisted Therapies
CALGARY, March 19, 2024 – A revolutionary step in mental...
READ MORE
ATMA CENA Psychedelic Healthcare Solutions Opens Psychedelic-assisted Therapy Clinic in Calgary and Provides Update of Its Clinic Network
CALGARY, March 14, 2024 – ATMA CENA Psychedelic Healthcare Solutions...
READ MORE
ATMA and Cena Life Launch The Nationwide Psychedelic-Assisted Therapy Healthcare Network
The initial launch of 10+ network clinics aims to support...
READ MORE
ATMA Is Developing Clinical Protocols and Training for Ketamine-Assisted Therapy to Treat Addictions in Collaboration with Dr. Aviva Fohrer
Dr. Aviva will offer invaluable insights derived from her two...
READ MORE
ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy
CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”),...
READ MORE
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy...
READ MORE
ATMA to Provide Psychedelic-Assisted Therapy Training in French and Spanish in the Fall
CALGARY, AB, May 4, 2023 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy...
READ MORE
